PT  - JOURNAL ARTICLE
AU  - Martínez-Cayuelas, Elena
AU  - Blanco-Kelly, Fiona
AU  - López-Grondona, Fermina
AU  - Tahsin-Swafiri, Saoud
AU  - López-Rodríguez, Rosario
AU  - Pozo, Rebeca Losada-Del
AU  - Mahillo, Ignacio
AU  - Moreno, Beatriz
AU  - Rodrigo-Moreno, María
AU  - Casas-Alba, Dídac
AU  - López-González, Aitor
AU  - García-Miñaur, Sixto
AU  - de los Ángeles Mori, María
AU  - Pacio-Mínguez, Marta
AU  - Rikeros-Orozco, Emi
AU  - Santos-Simarro, Fernando
AU  - Cruz-Rojo, Jaime
AU  - Quesada-Espinosa, Juan Francisco
AU  - Teresa Sánchez-Calvin, María
AU  - Pozo, Jaime Sánchez-del
AU  - Bernadó-Fonz, Raquel
AU  - Isidoro-García, María
AU  - Ruiz-Ayucar, Irene
AU  - Álvarez, María Isabel
AU  - Blanco-Lago, Raquel
AU  - De Azua-Brea, Begoña
AU  - Eirís, Jesús
AU  - García-Peñas, Juan José
AU  - Gil- Fournier, Belén
AU  - Gómez-Lado, Carmen
AU  - Irazabal, Nadia
AU  - López, Vanessa
AU  - Madrigal, Irene
AU  - Málaga, Ignacio
AU  - Martínez-Menéndez, Beatriz
AU  - Ramiro-Leon, María Soraya
AU  - García-Hoyos, María
AU  - Prieto-Matos, Pablo
AU  - López-Pisón, Javier
AU  - Aguilera-Albesa, Sergio
AU  - de Andrés, Sara Álvarez
AU  - Fernández-Jaén, Alberto
AU  - Llano-Rivas, Isabel
AU  - Gener, Blanca
AU  - Ayuso, Carmen
AU  - Arteche-López, Ana
AU  - Palomares-Bralo, María
AU  - Cueto, Anna
AU  - Valenzuela, Irene
AU  - Martínez-Monseny, Antonio F.
AU  - Lorda-Sánchez, Isabel
AU  - Almoguera, Berta
TI  - Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients
AID  - 10.1101/2022.04.11.22271283
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.11.22271283
4099  - http://medrxiv.org/content/early/2022/04/18/2022.04.11.22271283.short
4100  - http://medrxiv.org/content/early/2022/04/18/2022.04.11.22271283.full
AB  - Background KBG syndrome is a highly variable neurodevelopmental disorder and clinical diagnostic criteria have changed as new patients have been published. Both loss-of-function sequence variants and large deletions (CNVs) involving ANKRD11 have been involved in KBG, but no genotype-phenotype correlation has been reported to date. This study presents the clinical and molecular characteristics of 67 new patients with KBG syndrome and the results of the first genotype-phenotype correlation leveraging data on 273 patients previously published.Methods 67 patients with KBG syndrome were recruited through a Spanish collaborative effort and were assessed using a custom phenotypic questionnaire. The frequency of all features was calculated. Manifestations present in >50% of the patients and a “severity score” were used to perform a genotype-phenotype correlation in the 340 KBG patients.Results Neurodevelopmental delay (95%), comorbidites (82.8%), macrodontia (80.9%), triangular face (71%), characteristic ears (76%), nose (75.9%) and eyebrows (67.3%) were the most prevalent features in the 67 patients. The genotype-phenotype correlation yielded significant associations with the triangular face (71.1% in patients with sequence variants vs 45.2% in CNVs, p=0.015), short stature (62.5% variants in exon 9 vs. 27.8% outside; p=0.009) and macrodontia (with larger deletions, p=0.028), ID/ADHD/ASD (70.4% in c.1903_1907del vs. 89.4%; p=0.012) and a higher phenotypic score in patients with sequence variants compared with CNVs (p=0.005).Conclusions We present a detailed phenotypic description of KBG syndrome in the largest series of patients reported to date, provide evidence of a genotype-phenotype correlation between some KBG features and specific ANKRD11 aberrations, and propose updated clinical diagnostic criteria based on our findings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a Juan Rodes program (JR17/00020), a grant from Fondo de Investigaciones Sanitarias (FIS, PI18/01098), funded by Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Fundacion Jimenez Diaz University Hospital gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript